英国循环死亡后捐献心脏移植的国家试点项目
英国7个心脏移植中心开展国家多中心回顾性队列研究,采用直接获取和灌注技术由3个专业获取团队在全国范围内获取循环死亡后捐献心脏。2020年9月7日至2022年2月28日期间,50例循环死亡后捐献心脏被移植,同期179例脑死亡后捐献心脏被移植。循环死亡后捐献与脑死亡后捐献的30天生存率(94% vs 93%)和90天生存率(90% vs 90%)无差异,但循环死亡后捐献心脏移植后ECMO使用率更高(40% vs 16%,p=0.0006)。
要点
- 循环死亡后捐献心脏使英国整体心脏移植增加28%,早期生存与脑死亡后捐献相当。
- 循环死亡后捐献心脏移植后ECMO使用率高于脑死亡后捐献(40% vs 16%,p=0.0006)。
- 3个专业获取团队可为全国7个心脏移植中心获取循环死亡后捐献心脏。
核心结论
- 在该试点研究中,3个专业获取团队能够为英国全部7个心脏移植中心在全国范围内获取循环死亡后捐献心脏,循环死亡后捐献供体使英国整体心脏移植增加28%,与脑死亡后捐献供体相比早期移植后生存相当。
研究设计与样本
- 国家多中心回顾性队列研究,分析英国7个成人及儿童心脏移植中心开展的循环死亡后捐献心脏移植的早期结局。
- 心脏通过直接获取和灌注技术由3个接受离体常温机器灌注培训的专业获取团队获取。
- 结局与全国试点时代之前的循环死亡后捐献心脏移植以及同期脑死亡后捐献心脏移植进行比较,采用Kaplan-Meier分析、卡方检验和Wilcoxon秩和检验。
主要发现
- 2020年9月7日至2022年2月28日期间,共提供215个潜在循环死亡后捐献心脏,其中98个(46%)被接受并到场获取。
- 77个潜在供体(36%)在2小时内进展至死亡,57个(27%)供体心脏成功获取并离体灌注,50个(23%)循环死亡后捐献心脏最终被移植。
- 同期共移植179个脑死亡后捐献心脏。
- 循环死亡后捐献与脑死亡后捐献的30天生存率无差异(94% vs 93%),90天生存率也无差异(90% vs 90%)。
- 循环死亡后捐献心脏移植后ECMO使用率高于脑死亡后捐献(40% vs 16%,p=0.0006),也高于试点时代前的循环死亡后捐献心脏(17%,p=0.002)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The United Kingdom (UK) was one of the first countries to pioneer heart transplantation from donation after circulatory death (DCD) donors. To facilitate equity of access to DCD hearts by all UK heart transplant centers and expand the retrieval zone nationwide, a Joint Innovation Fund (JIF) pilot was provided by NHS Blood and Transplant (NHSBT) and NHS England (NHSE). The activity and outcomes of this national DCD heart pilot program are reported. METHODS: This is a national multi-center, retrospective cohort study examining early outcomes of DCD heart transplants performed across 7 heart transplant centers, adult and pediatric, throughout the UK. Hearts were retrieved using the direct procurement and perfusion (DPP) technique by 3 specialist retrieval teams trained in ex-situ normothermic machine perfusion. Outcomes were compared against DCD heart transplants before the national pilot era and against contemporaneous donation after brain death (DBD) heart transplants, and analyzed using Kaplan-Meier analysis, chi-square test, and Wilcoxon's rank-sum. RESULTS: From September 7, 2020 to February 28, 2022, 215 potential DCD hearts were offered of which 98 (46%) were accepted and attended. There were 77 potential donors (36%) which proceeded to death within 2 hours, with 57 (27%) donor hearts successfully retrieved and perfused ex situ and 50 (23%) DCD hearts going on to be transplanted. During this same period, 179 DBD hearts were transplanted. Overall, there was no difference in the 30-day survival rate between DCD and DBD (94% vs 93%) or 90 day survival (90% vs 90%) respectively. There was a higher rate of ECMO use post-DCD heart transplants compared to DBD (40% vs 16%, p = 0.0006), and DCD hearts in the pre pilot era, (17%, p = 0.002). There was no difference in length of ICU stay (9 DCD vs 8 days DBD, p = 0.13) nor hospital stay (28 DCD vs 27 DBD days, p = 0.46). CONCLUSION: During this pilot study, 3 specialist retrieval teams were able to retrieve DCD hearts nationally for all 7 UK heart transplant centers. DCD donors increased overall heart transplantation in the UK by 28% with equivalent early posttransplant survival compared with DBD donors.
引用
- Messer S, Rushton S, Simmonds L, et al. A national pilot of donation after circulatory death (DCD) heart transplantation within the United Kingdom. J Heart Lung Transplant. 2023. PMID: 37032222. doi:10.1016/j.healun.2023.03.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。